Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST-segment elevation myocardial infarction: A meta-analysis of 15 randomized trials

Catheterization and Cardiovascular Interventions

Volumn 84, Issue 6, 2014, Pages 978-986

  Khalili, Houman ^a   Patel, Vishal G ^a   Mayo, Helen G ^a   De Lemos, James A ^a   Brilakis, Emmanouil S ^a,b   Banerjee, Subhash ^a,b   Bavry, Anthony A ^c   Bhatt, Deepak L ^d   Kumbhani, Dharam J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Veterans Administration   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Ischemic conditioning; Meta analysis; Mortality; Myocardial infarction; Outcome

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; FOLLOW UP; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC POSTCONDITIONING; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THERAPY EFFECT; TREATMENT OUTCOME; ADVERSE EFFECTS; MORTALITY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RISK FACTOR; TIME;

HUMANS; ISCHEMIC POSTCONDITIONING; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84930087619     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.25581     Document Type: Article

References (49)

1. Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schomig A, Kastrati A. Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol 2007;50:149-156.
2. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet 2013;381:166-75.
3. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
4. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588.
5. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999;354:1896-1900.
6. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
7. Haldane JB. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-311.
8. Kumbhani DJ, Bavry AA, Desai MY, et al. Aspiration thrombectomy in patients undergoing primary angioplasty: Totality of data to 2013. Catheter Cardiovasc Interv 2014 May 27. doi: 10.1002/ccd.25532; [Epub ahead of print].
9. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
10. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 2009;62:1006-1012.
11. Dwyer NB, Mikami Y, Hilland D, et al. No cardioprotective benefit of ischemic postconditioning in patients with ST-segment elevation myocardial infarction. J Interv Cardiol 2013;26:482-490.
12. Elzbieciak M, Wita K, Grabka M, et al. Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement in left ventricular systolic function in patients with first anterior STsegment elevation myocardial infarction. Pol Arch Med Wewn 2013;123:268-276.
13. Freixa X, Bellera N, Ortiz-Perez JT, et al. Ischaemic postconditioning revisited: Lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J 2012;33: 103-112.
14. Garcia S, Henry TD, Wang YL, et al. Long-term follow-up of patients undergoing postconditioning during ST-elevation myocardial infarction. J Cardiovasc Transl Res 2011;4:92-98.
15. Hahn JY, Song YB, Kim EK, et al. Ischemic postconditioning during primary percutaneous coronary intervention: The effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 2013;128:1889-1896.
16. Laskey WK, Yoon S, Calzada N, Ricciardi MJ. Concordant improvements in coronary flow reserve and ST-segment resolution during percutaneous coronary intervention for acute myocardial infarction: A benefit of postconditioning. Catheter Cardiovasc Interv 2008;72:212-220.
17. Lin XM, Zhang ZY, Wang LF, et al. Attenuation of tumor necrosis factor-alpha elevation and improved heart function by postconditioning for 60 seconds in patients with acute myocardial infarction. Chin Med J (Engl) 2010;123:1833-1839.
18. Lonborg J, Holmvang L, Kelbaek H, et al. ST-Segment resolution and clinical outcome with ischemic postconditioning and comparison to magnetic resonance. Am Heart J 2010;160:1085-1091.
19. Sorensson P, Saleh N, Bouvier F, et al. Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction. Heart 2010;96:1710-1715.
20. Tarantini G, Favaretto E, Marra MP, et al. Postconditioning during coronary angioplasty in acute myocardial infarction: The POST-AMI trial. Int J Cardiol 2012;162:33-38.
21. Thibault H, Piot C, Staat P, et al. Long-term benefit of postconditioning. Circulation 2008;117:1037-1044.
22. Thuny F, Lairez O, Roubille F, et al. Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2012;59:2175-2181.
23. Xue F, Yang X, Zhang B, et al. Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 2010; 33:439-444.
24. Yang XC, Liu Y, Wang LF, et al. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention. J Invasive Cardiol 2007;19:424-430.
25. Zhao CM, Yang XJ, Yang JH, et al. Effect of ischaemic postconditioning on recovery of left ventricular contractile function after acute myocardial infarction. J Int Med Res 2012;40:1082- 1088.
26. Lonborg J, Kelbaek H, Vejlstrup N, et al. Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 2010;3:34-41.
27. Hansen PR, Thibault H, Abdulla J. Postconditioning during primary percutaneous coronary intervention: A review and metaanalysis. Int J Cardiol 2010;144:22-25.
28. Wang L, Wang J, Xu H, Li B. Postconditioning in patients treated with primary percutaneous coronary intervention: An updated meta-analysis. Catheter Cardiovasc Interv 2013;82:E662-E671.
29. Wei Y, Ruan L, Zhou G, et al. Local ischemic postconditioning during primary percutaneous coronary intervention: A metaanalysis. Cardiology 2012;123:225-233.
30. Zhou C, Yao Y, Zheng Z, et al. Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: A systematic review of 10 randomized trials. Eur Heart J 2012;33:3070-3077.
31. Greupner J, Zimmermann E, Grohmann A, et al. Head-to-head comparison of left ventricular function assessment with 64-row computed tomography, biplane left cineventriculography, and both 2- and 3-dimensional transthoracic echocardiography: Comparison with magnetic resonance imaging as the reference standard. J Am Coll Cardiol 2012;59:1897-1907.
32. Bhatt DL. Evaluation of agents to reduce infarct size: it can be quite REVEALing. JAMA 2011;305:1908-1909.
33. Laskey WK, Schevchuck A. Postconditioning during percutaneous coronary intervention in acute myocardial infarction: continued difficulty in translation. Circulation 2013;128:1858-1860.
34. Van der Heide RS, Steenbergen C. Cardioprotection and myocardial reperfusion: Pitfalls to clinical application. Circ Res 2013; 113:464-477.
35. Botker HE, Kharbanda R, Schmidt MR, et al. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: A randomised trial. Lancet 2010; 375:727-734.
36. Crimi G, Pica S, Raineri C, et al. Remote ischemic postconditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: A randomized controlled trial. J Am Coll Cardiol Intv 2013;6:1055-1063.
37. Sloth AD, Schmidt MR, Munk K, et al. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention. Eur Heart J 2014;35:168-175.
38. Miura T, Miki T. Limitation of myocardial infarct size in the clinical setting: Current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 2008; 103:501-513.
39. Kumbhani DJ, Healey NA, Birjiniuk V, et al. Determinants of regional myocardial acidosis during cardiac surgery. Surgery 2004;136:190-198.
40. Heusch G. Postconditioning: Old wine in a new bottle? J Am Coll Cardiol 2004;44:1111-1112.
41. Laskey WK. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: A pilot study. Catheter Cardiovasc Interv 2005;65:361-367.
42. Staat P, Rioufol G, Piot C, et al. Postconditioning the human heart. Circulation 2005;112:2143-2148.
43. Kumbhani DJ, Bavry AA, Desai MY, Bangalore S, Bhatt DL. Role of aspiration and mechanical thrombectomy in patients with acute myocardial infarction undergoing primary angioplasty: An updated meta-analysis of randomized trials. J Am Coll Cardiol 2013;62:1409-1418.
44. Svilaas T, Vlaar PJ, van der Horst IC, et al. Thrombus aspiration during primary percutaneous coronary intervention. N Engl J Med 2008;358:557-567.
45. Ortiz-Perez JT, Meyers SN, Lee DC, et al. Angiographic estimates of myocardium at risk during acute myocardial infarction: Validation study using cardiac magnetic resonance imaging. Eur Heart J 2007;28:1750-1758.
46. Hausenloy DJ, Erik Botker H, Condorelli G, et al. Translating cardioprotection for patient benefit: Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2013;98:7-27.
47. Roubille F, Lairez O, Mewton N, et al. Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: A retrospective analysis. Basic Res Cardiol 2012;107:275.
48. Yang XM, Liu Y, Cui L, et al. Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther 2013;27:109-115.
49. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: The AMISTAD-2 trial. Eur Heart J 2006;27:2400-2405.